- Home
- TENX vs OVID Comparison
TENX vs OVID Comparison
Compare TENX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- OVID
- Stock Information
- Founded
- TENX 1967
- OVID 2014
- Country
- TENX United States
- OVID United States
- Employees
- TENX N/A
- OVID N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- TENX Health Care
- OVID Health Care
- Exchange
- TENX Nasdaq
- OVID Nasdaq
- Market Cap
- TENX 21.6M
- OVID 20.6M
- IPO Year
- TENX N/A
- OVID 2017
- Fundamental
- Price
- TENX $6.06
- OVID $0.32
- Analyst Decision
- TENX Strong Buy
- OVID Strong Buy
- Analyst Count
- TENX 3
- OVID 6
- Target Price
- TENX $16.00
- OVID $2.78
- AVG Volume (30 Days)
- TENX 11.9K
- OVID 650.4K
- Earning Date
- TENX 05-14-2025
- OVID 05-13-2025
- Dividend Yield
- TENX N/A
- OVID N/A
- EPS Growth
- TENX N/A
- OVID N/A
- EPS
- TENX N/A
- OVID N/A
- Revenue
- TENX N/A
- OVID $548,000.00
- Revenue This Year
- TENX N/A
- OVID N/A
- Revenue Next Year
- TENX N/A
- OVID $28.16
- P/E Ratio
- TENX N/A
- OVID N/A
- Revenue Growth
- TENX N/A
- OVID 15.61
- 52 Week Low
- TENX $2.77
- OVID $0.24
- 52 Week High
- TENX $7.89
- OVID $3.31
- Technical
- Relative Strength Index (RSI)
- TENX 55.80
- OVID 55.40
- Support Level
- TENX $5.60
- OVID $0.27
- Resistance Level
- TENX $6.31
- OVID $0.32
- Average True Range (ATR)
- TENX 0.27
- OVID 0.02
- MACD
- TENX -0.01
- OVID 0.01
- Stochastic Oscillator
- TENX 63.31
- OVID 75.23
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.